<DOC>
	<DOC>NCT02452957</DOC>
	<brief_summary>The aim of this observationnal post-marketing study is to provide additional information on the safety and effectiveness of Simpliciti™ system at 24 months post-shoulder arthroplasty , in usual surgical practice.</brief_summary>
	<brief_title>Safety and Effectiveness of the Tornier Simpliciti™ Shoulder System in Shoulder Arthroplasty</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<criteria>A subject must meet all of the following inclusion criteria in order to enter the study: Adult subject 18 years or older, Clinical indication for total shoulder or hemi replacement due to primary diagnosis of osteoarthritis, Scapula and proximal humerus must have reached skeletal maturity, Willing and able to comply with the protocol, Willing and able to personally sign the informed consent form, Subject is legally competent, understands the nature, significance and implications of the clinical investigation, and is able to form a rational intention in the light of these facts. A subject will not be eligible to participate in the study if any of the following conditions is present: lack of sufficient sound bone to seat and support the implant, including that resulting from skeletal immaturity, osteoporosis or erosive arthritis, Severe Walch grade B2 glenoid defined as &gt;60% posterior head displacement and &gt;20% posterior glenoid bone loss, metal allergies or sensitivity, infection at or near the site of implantation, distant or systemic infection.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2015</verification_date>
</DOC>